News

BioMed SA eyes new road map to greater economic wins

BioMed SA President Ann Stevens (Photo by Lyndsey Johnson) By W. Scott Bailey, San Antonio Business ...

Diabetes, Infectious Diseases Early Focus of San Antonio Biomed Plan

David Holley, Xconomy Texas —  San Antonio — [Updated 12/14/17, 11:54 p.m. See below.] ...

Industry Publications

The Mission

The Mission is published by the University of Texas Health Science Center.

UTSA Discovery

UTSA Discovery is published annually for the Office of the Vice President for Research by the Office ...

News
BIOMED SA JOINS NATIONAL CONSORTIUM TO ADVANCE NEW TECHNOLOGIES TO MEET MILITARY MEDICAL NEEDS
March 16, 2016

 

SAN ANTONIO (March 16, 2016) - BioMed SA announced that it has joined a newly formed national biotechnology consortium to promote collaborative R&D aimed at advancing state-of-the-art technologies to meet military medical needs and improve medical practice.

The Medical Technology Enterprise Consortium (MTEC) is a first-of-its-kind vehicle for combining traditional government-funded prototyping initiatives with private sector funding.

MTEC operates under a 10-year renewable Other Transaction Agreement with the U.S. Army Medical Research and Materiel Command. It will support USAMRMC requirements for biomedical research and prototyping, capitalization of private sector technology opportunities, technology transfer, commercialization, and follow-on production.

MTEC is recruiting a broad and diverse membership from across the nation including large businesses, small businesses, non-traditional government contractors, academic research institutions, and not-for-profit organizations.

"As a multi-member organization, BioMed SA will serve as an information clearinghouse, providing access to information on funding opportunities that may not be available elsewhere," explained BioMed SA President Ann Stevens.

BioMed SA member companies and institutions can join the consortium themselves in order to bid on and receive funding awards.

MTEC recently released its first funding solicitation for regenerative medicine manufacturing. Future solicitations will address infectious diseases, combat casualty care, operational medicine, vision restoration, clinical and rehabilitative medicine, medical training and health information science, chemical and biological agents and radiation, and advanced medical technologies.

To learn more about MTEC, visit www.mtec-sc.org   For more on BioMed SA, visit: www.biomedsa.org

Stay informed. Subscribe to BioMed SA news alerts.